Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Electrochemotherapy for Colorectal Liver Metastases
NCT02352259Phase 2Completed
- Sponsor
- Institute of Oncology Ljubljana
- Start
- Sep 2013
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bleomycin in colorectal liver metastases (CRLM), sponsored by Institute of Oncology Ljubljana. Primary endpoint: Evaluation of Safety Related to Electrochemotherapy at 7 days. Started Sep 2013; status: completed.
02
Drugs
bleomycin
03
Conditions
colorectal liver metastases (CRLM)
Beyond the preview
Go deeper on NCT02352259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02352259.